Women's Testosterone Test: Levels & What to Check

Key Takeaways: Women need a different testosterone testing panel than men, with more sensitive assays and additional markers like DHEA-S, SHBG, and progesterone. Normal reference ranges for women are roughly 1/10th of male ranges, and the difference between "normal" and "optimal" can mean the difference between feeling fine and feeling terrible. Timing matters -- test on days 3-7 of your menstrual cycle, fasting, before 10 AM.

Most women who suspect low testosterone run into the same problem: their doctor orders the wrong tests, uses the wrong assay, or interprets results against male-calibrated reference ranges. The result is a lab report that says "normal" when the patient clearly is not.

Women's testosterone testing requires a specific panel, specific timing, and specific interpretation. This guide covers exactly what to order, when to draw blood, and what the numbers actually mean.

Why Standard Testing Fails Women

The testosterone testing infrastructure was built for men. Most commercial immunoassays are calibrated for male ranges (300-1000 ng/dL) and lose accuracy at the low concentrations found in women (15-70 ng/dL for total testosterone). A test with a margin of error of +/- 50 ng/dL is irrelevant for a man at 500 ng/dL but catastrophic for a woman at 30 ng/dL.

This is not theoretical. The Endocrine Society has explicitly stated that standard immunoassays are unreliable for measuring testosterone in women and recommends liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the preferred method (PMID: 25279570). If your lab report does not specify the assay method, ask. If they used a standard immunoassay, the result may be meaningless.

Beyond the assay problem, reference ranges on lab reports are generated from population averages that include women on oral contraceptives (which suppress testosterone) and women with PCOS (which elevates it). These ranges are so wide they capture almost everyone as "normal."

The Complete Women's Testosterone Panel

Do not order a single testosterone test and call it done. Testosterone in women is influenced by SHBG, adrenal function, and ovarian output. You need the full picture.

Essential Tests (Non-Negotiable)

Total Testosterone (via LC-MS/MS) The foundation. Measures all testosterone in your blood -- bound and unbound. In premenopausal women, expect 15-70 ng/dL. The key is ensuring the lab uses LC-MS/MS, not standard immunoassay.

Free Testosterone (calculated or equilibrium dialysis) This is what actually matters for symptoms. Only 1-3% of total testosterone is free and available to tissues. The rest is bound to SHBG (65-80%) or albumin (20-30%). Equilibrium dialysis is the gold standard; calculated free testosterone using the Vermeulen equation is an acceptable alternative.

Sex Hormone-Binding Globulin (SHBG) The gatekeeper. SHBG binds testosterone and renders it inactive. High SHBG means less free testosterone regardless of your total level. Oral contraceptives, thyroid medication, liver conditions, and low-calorie diets all raise SHBG. This single marker explains why many women have "normal" total testosterone but low-testosterone symptoms.

DHEA-S (Dehydroepiandrosterone Sulfate) Your adrenal androgen marker. About 50% of a woman's androgens originate from adrenal precursors, primarily DHEA and DHEA-S, which are converted to testosterone in peripheral tissues (PMID: 9253307). DHEA-S declines roughly 2-3% per year starting in the mid-20s. By menopause, most women have lost 60% or more of their peak DHEA-S. If DHEA-S is low alongside low testosterone, the problem is likely adrenal rather than ovarian.

Critical Complementary Markers

Estradiol (E2) Testosterone and estradiol work together. Estradiol levels contextualize testosterone results -- the ratio between them matters as much as the individual values. In premenopausal women, estradiol fluctuates significantly across the cycle, so interpreting it requires knowing when in the cycle the blood was drawn.

Progesterone Confirms ovulation when drawn in the luteal phase (days 19-22). Low progesterone suggests anovulatory cycles, which are often linked to broader hormonal disruption including androgen imbalance. On days 3-7 (when you test testosterone), progesterone should be low -- if it is elevated, the timing is off.

Prolactin Elevated prolactin suppresses the entire hypothalamic-pituitary-gonadal axis, including testosterone production. Rule it out before attributing low testosterone to aging or menopause.

Thyroid Panel (TSH + Free T4) Hypothyroidism mimics many low-testosterone symptoms (fatigue, brain fog, weight gain, low libido) and also affects SHBG levels. Always check.

When to Test: Cycle Timing Is Everything

For premenopausal women, testosterone fluctuates across the menstrual cycle. Testing at the wrong time produces misleading results.

The Testing Window: Days 3-7

Draw blood during the early follicular phase (days 3-7 of your cycle), counting day 1 as the first day of your period. This window provides the most stable baseline testosterone reading.

Testosterone rises toward mid-cycle, peaking around ovulation (days 12-14) before declining in the luteal phase. A mid-cycle draw can show a level 20-30% higher than your true baseline. An ovulation-day draw may show your "peak" rather than your average.

Other Timing Rules

• Morning draw (before 10 AM). Testosterone follows a diurnal rhythm in women, though the variation is less pronounced than in men. Morning levels are the most reproducible.
• Fasting (8-12 hours). Glucose intake acutely suppresses testosterone. Water and black coffee are fine.
• Avoid testing during acute illness, extreme stress, or significant sleep deprivation. All temporarily suppress the HPG axis.
• If on oral contraceptives: Understand that your results will show suppressed free testosterone due to elevated SHBG. This is the pill's pharmacological effect, not your natural baseline. For accurate baseline assessment, test 6-8 weeks after discontinuation.

Postmenopausal Women

Cycle timing is irrelevant after menopause. Test any morning, fasting, before 10 AM. The same panel applies. Expect lower total and free testosterone compared to premenopausal ranges.

Perimenopause

This is the most challenging testing scenario. Cycles become irregular, making it difficult to identify day 3-7. If your cycles are unpredictable, draw blood during any light-flow or early-bleed day. If periods have stopped for 2+ months, treat it as postmenopausal timing.

Normal vs. Optimal Ranges: What the Numbers Mean

Here is where most confusion lives. Lab reference ranges and clinical optimal ranges are not the same thing.

Reference ranges represent the 2.5th to 97.5th percentile of the tested population. Being "in range" means you fall somewhere within 95% of the population -- including people who feel terrible. Optimal ranges represent where most women report feeling their best, based on clinical outcomes data and the 2019 Global Consensus Position Statement (PMID: 31488288).

Premenopausal Women (Ages 18-45)

Marker	Lab Reference Range	Optimal Range	Unit
Total Testosterone	8-60 ng/dL	30-50 ng/dL	ng/dL
Free Testosterone	0.5-5.0 pg/mL	2.0-4.0 pg/mL	pg/mL
SHBG	18-144 nmol/L	40-80 nmol/L	nmol/L
DHEA-S	65-380 mcg/dL	150-300 mcg/dL	mcg/dL
Estradiol (follicular)	15-350 pg/mL	30-100 pg/mL	pg/mL
Progesterone (luteal)	1.8-24 ng/mL	10-20 ng/mL	ng/mL
Prolactin	2-29 ng/mL	5-20 ng/mL	ng/mL

Postmenopausal Women

Marker	Lab Reference Range	Optimal Range	Unit
Total Testosterone	5-32 ng/dL	15-25 ng/dL	ng/dL
Free Testosterone	0.2-3.0 pg/mL	1.0-2.5 pg/mL	pg/mL
SHBG	20-130 nmol/L	30-70 nmol/L	nmol/L
DHEA-S	30-260 mcg/dL	100-200 mcg/dL	mcg/dL
Estradiol	<10-40 pg/mL	Depends on HRT status	pg/mL
Prolactin	2-20 ng/mL	5-15 ng/mL	ng/mL

A woman with a total testosterone of 12 ng/dL is technically "in range" for most labs. She is also likely experiencing fatigue, low libido, muscle loss, and brain fog. The number is not clinically optimal -- it is just not flagged.

Reference ranges derived from LC-MS/MS methods in healthy premenopausal women show more useful boundaries (PMID: 21771278, PMID: 22162468). The problem is that most labs still use older immunoassay-based ranges.

How to Interpret Your Results

Raw numbers mean nothing without context. Here is how to read your panel like a clinician.

Pattern 1: Low Total T + Low Free T + Normal SHBG

What it means: True testosterone deficiency. Your body is not making enough testosterone.

Likely cause: Age-related decline, adrenal insufficiency, oophorectomy, or hypothalamic-pituitary dysfunction. Check DHEA-S -- if it is also low, the adrenals are underperforming. If DHEA-S is normal but testosterone is low, the issue is more likely ovarian.

Next step: Evaluate LH and FSH to determine if the problem is central (pituitary) or peripheral (ovarian/adrenal). Consider HRT consultation.

Pattern 2: Low Free T + Normal Total T + High SHBG

What it means: You are making testosterone, but SHBG is binding most of it. Functionally, you are testosterone-deficient even though total T looks fine.

Common causes: Oral contraceptives (the single most common cause in younger women), thyroid medication, very low-calorie diets, liver conditions, or high estrogen states.

Next step: Address the SHBG driver. Discontinue oral contraceptives if appropriate (switch to non-hormonal or progestin-only methods). Evaluate thyroid. If SHBG remains elevated without a correctable cause, HRT may be appropriate.

Pattern 3: High Total T + Normal or High Free T

What it means: Elevated testosterone, which in women suggests PCOS, adrenal hyperplasia, or (rarely) an androgen-producing tumor.

Supporting clues: Acne, hirsutism, irregular cycles, insulin resistance. Check androstenedione and 17-hydroxyprogesterone to differentiate adrenal from ovarian sources.

Next step: Full PCOS workup including fasting insulin, glucose, lipids, and pelvic ultrasound. See Testosterone and PCOS for details.

Pattern 4: Low DHEA-S + Low Total T + Fatigue

What it means: Adrenal androgen depletion, often called "adrenal fatigue" in popular health media. The more accurate description is age-related adrenal androgen decline or adrenal insufficiency.

Context: DHEA-S production declines progressively from the mid-20s onward. By 60, most women produce less than 20% of their peak DHEA-S (PMID: 9253307). This decline contributes significantly to overall androgen deficiency in aging women.

Next step: Cortisol testing (AM cortisol or ACTH stimulation test) to rule out true adrenal insufficiency. DHEA supplementation may be appropriate under medical supervision.

Pattern 5: Normal Labs + Clear Symptoms

This happens more than clinicians acknowledge. A woman with a total testosterone of 25 ng/dL and free testosterone of 1.5 pg/mL is technically "normal" but may have been at 50 ng/dL and 3.5 pg/mL five years ago. The decline is clinically significant even if the current value is still within range.

This is why the ISSWSH clinical practice guideline emphasizes that there is no testosterone level below which women can be reliably diagnosed with androgen deficiency (PMID: 33814355). Symptoms must be weighed alongside labs, not overridden by them.

What Low Testosterone Looks Like: Labs vs. Symptoms

Lab values and symptoms do not always align perfectly. The Davis et al. 2019 Lancet meta-analysis confirmed that testosterone therapy improved sexual desire, arousal, orgasm, and satisfaction in postmenopausal women -- but crucially, the women who benefited most were those with symptoms, not those with the lowest lab values (PMID: 31353194).

Symptoms That Correlate With Low Testosterone

• Decreased or absent libido (the most validated symptom)
• Persistent fatigue unresponsive to sleep and lifestyle changes
• Loss of muscle mass despite regular exercise
• Unexplained weight gain, especially around the midsection
• Brain fog, difficulty concentrating, word-finding problems
• Depressed mood or flat affect (not responsive to antidepressants)
• Thinning hair
• Decreased exercise recovery and stamina

If you have three or more of these symptoms alongside labs showing total testosterone in the lower third of the reference range, free testosterone below optimal, or SHBG above 80 nmol/L, the clinical picture supports testosterone deficiency. See Low Testosterone Symptoms in Women: 12 Signs for the full breakdown.

Common Mistakes to Avoid

Testing only total testosterone. Without free testosterone and SHBG, total testosterone is incomplete. A woman on oral contraceptives with total T of 35 ng/dL could have a free T of 0.5 pg/mL -- functionally deficient.

Using the wrong assay. Standard immunoassays are unreliable below 100 ng/dL. Insist on LC-MS/MS for total testosterone. If your lab cannot accommodate this, use a lab that can.

Testing at the wrong time. Mid-cycle or afternoon draws in premenopausal women produce unreliable baselines. Always days 3-7, morning, fasting.

Ignoring DHEA-S. In women over 35, adrenal androgen decline is often the primary driver of low testosterone symptoms. Skipping DHEA-S misses half the picture.

Comparing to male ranges. Some older lab reports use unisex reference ranges or do not have female-specific ranges. A total testosterone of 30 ng/dL is critically low for a man and perfectly normal for a woman.

Testing once and making a diagnosis. Testosterone fluctuates day to day. The Global Consensus Position Statement recommends at least two separate measurements before clinical decision-making (PMID: 31488288).

Where to Get Tested

Through Your Doctor

An HRT-specialized provider will know the correct panel, assay, and timing. General practitioners often order total testosterone alone using immunoassay -- push for the comprehensive panel described above. If your doctor is unfamiliar with LC-MS/MS or women's androgen testing, consider an HRT clinic.

Browse Best Online HRT Clinics for Women for providers who specialize in women's hormone optimization.

Direct-to-Consumer Labs

Quest Diagnostics and LabCorp both offer self-pay hormone panels. Look for panels that include total testosterone (LC-MS/MS), free testosterone, SHBG, DHEA-S, and estradiol at minimum. Expect to pay $100-250 depending on comprehensiveness.

Online lab ordering services (Discounted Labs, Walk-In Lab) often offer female hormone panels at lower prices than ordering through a clinic.

What to Bring to Your Appointment

When reviewing results with your provider:

• Your lab report with assay methods specified
• A list of all medications and supplements (especially oral contraceptives, thyroid medication, and corticosteroids)
• Your cycle day at the time of the draw
• A symptom log covering the prior 4-6 weeks

For a deeper dive on interpreting your results, read How to Read Testosterone Labs and How to Test Testosterone.

Next Steps After Testing

If your results suggest low testosterone:

1. Rule out correctable causes. Oral contraceptives, thyroid dysfunction, high prolactin, severe caloric restriction, and chronic stress all suppress testosterone or elevate SHBG. Fix these first.
2. Get a second draw. One low result is not diagnostic. Repeat in 2-4 weeks, same cycle timing.
3. Consult an HRT specialist. General practitioners may not be comfortable prescribing testosterone for women. HRT clinics that work with women understand the dosing, monitoring, and nuances. See Testosterone for Women: Complete Guide.
4. Discuss treatment options. Transdermal testosterone (creams, gels, patches) is the recommended delivery method for women per the Global Consensus Position Statement. Oral testosterone is not recommended due to liver metabolism and lipid effects.

---

References

1. Wierman ME, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489-3510. PMID: 25279570
2. Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID: 31488288
3. Islam RM, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754-766. PMID: 31353194
4. Parish SJ, et al. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med. 2021;18(5):849-867. PMID: 33814355
5. Labrie F, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab. 1997;82(8):2396-2402. PMID: 9253307
6. Rothman MS, et al. Testosterone reference ranges in normally cycling healthy premenopausal women. J Sex Med. 2011;8(10):2924-2934. PMID: 21771278
7. Handelsman DJ, et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2012;97(2):408-415. PMID: 22162468